Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis.
Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis. Aliment Pharmacol Ther. 2023 01; 57(1):150-151.